Consistency of response by weight across subgroups of patients with psoriasis treated with guselkumab: Results from the VOYAGE 1 and 2 trials

Objective: To evaluate the consistency of response of guselkumab (GUS) across predetermined weight quartile subgroups of psoriasis patients.

https://ift.tt/2MA74nt